The pro-cirrhotic effect of the MZ genotype was associated with the presence of intrahepatic AAT aggregates, which were of greater extent and density in liver explants in patients with ALD and NASH than in cirrhotic patients with other chronic liver diseases. This evidence concerns the gene SERPINA1 and metabolic dysfunction-associated steatohepatitis.